-
EP3795177
European procedure
Extract from the Register of European Patents
EP About this file: EP3795177
| EP3795177 - CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.02.2023 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 11.03.2022 | ||
| Former | Grant of patent is intended Status updated on 04.11.2021 | ||
| Former | Request for examination was made Status updated on 18.06.2021 | ||
| Former | The application has been published Status updated on 19.02.2021 | Most recent event Tooltip | 17.02.2023 | No opposition filed within time limit | published on 22.03.2023 [2023/12] | Applicant(s) | For all designated states BioNTech Cell & Gene Therapies GmbH An der Goldgrube 12 55131 Mainz / DE | For all designated states TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH Freiligrathstrasse 12 55131 Mainz / DE | [2021/12] | Inventor(s) | 01 /
SAHIN, Ugur Philipp-von-Zabern-Platz 1 55116 Mainz / DE | 02 /
TÜRECI, Özlem Philipp-von-Zabern-Platz 1 55116 Mainz / DE | 03 /
SIMON, Petra Silvanerstraße 33 55129 Mainz / DE | 04 /
OMOKOKO, Tana Franz-Werfel-Straße 20 55122 Mainz / DE | 05 /
BREITKREUZ, Andrea Trifelsstraße 47 67551 Worms / DE | 06 /
MROZ, Karolina Anna Zietenring 3 65195 Wiesbaden / DE | 07 /
HEBICH, Lisa Steinäckersiedlung 3 67304 Kerzenheim / DE | [2022/15] |
| Former [2021/12] | 01 /
SAHIN, Ugur Philipp-von-Zabern-Platz 1 55116 Mainz / DE | ||
| 02 /
TÜRECI, Özlem Philipp-von-Zabern-Platz 1 55116 Mainz / DE | |||
| 03 /
SIMON, Petra Silvanerstrasse 33 55129 Mainz / DE | |||
| 04 /
OMOKOKO, Tana Franz-Werfel-Strasse 20 55122 Mainz / DE | |||
| 05 /
BREITKREUZ, Andrea Trifelsstrasse 47 67551 Worms / DE | |||
| 06 /
MROZ, Karolina Anna Zietenring 3 65195 Wiesbaden / DE | |||
| 07 /
HEBICH, Lisa Steinäckersiedlung 3 67304 Kerzenheim / DE | Representative(s) | Müller, Christian Stefan Gerd ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2021/12] | Application number, filing date | 20193185.4 | 09.05.2016 | [2021/12] | Priority number, date | WO2015EP60357 | 11.05.2015 Original published format: PCT/EP2015/060357 | [2021/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3795177 | Date: | 24.03.2021 | Language: | EN | [2021/12] | Type: | B1 Patent specification | No.: | EP3795177 | Date: | 13.04.2022 | Language: | EN | [2022/15] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.02.2021 | Classification | IPC: | A61K39/395, C07K14/725, C07K7/06, C07K14/47, A61P35/00 | [2021/12] | CPC: |
C07K14/7051 (EP,CN,KR,US);
C07K14/70539 (CN,US);
A61K39/0011 (EP,CN,KR,US);
A61K40/11 (EP,CN,KR,US);
A61K40/31 (EP,CN,KR,US);
A61K40/32 (EP,CN,KR,US);
A61K40/4202 (EP,CN,KR,US);
A61P35/00 (EP,CN,KR);
A61P37/04 (EP,CN);
C07K14/705 (US);
C07K14/70521 (EP,US);
C07K16/18 (KR);
C07K16/28 (EP,CN,US);
C07K7/06 (EP,US);
C12N5/0636 (EP,CN,KR,US);
A61K2039/572 (CN,US);
A61K2039/575 (CN,US);
C07K2317/34 (CN,US);
C07K2317/56 (CN,US);
C07K2317/565 (CN,US);
C07K2317/622 (CN,US);
C07K2317/73 (CN,US);
C07K2317/76 (CN,US);
C07K2319/02 (CN,KR,US);
C07K2319/03 (EP,CN,KR,US);
C07K2319/035 (CN,US);
C07K2319/30 (CN,US);
C07K2319/33 (EP,CN,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/29] |
| Former [2021/12] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 16.06.2021 | ME | 16.06.2021 | Title | German: | CLAUDIN-18.2-SPEZIFISCHE IMMUNREZEPTOREN UND T-ZELL-EPITOPE | [2021/12] | English: | CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES | [2021/12] | French: | IMMUNORÉCEPTEURS ET ÉPITOPES DE LYMPHOCYTES T SPÉCIFIQUES DE LA CLAUDINE-18.2 | [2021/12] | Examination procedure | 16.06.2021 | Amendment by applicant (claims and/or description) | 16.06.2021 | Examination requested [2021/29] | 16.06.2021 | Date on which the examining division has become responsible | 05.11.2021 | Communication of intention to grant the patent | 03.03.2022 | Fee for grant paid | 03.03.2022 | Fee for publishing/printing paid | 03.03.2022 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP16721176.2 / EP3294333 | Divisional application(s) | EP22166898.1 / EP4082565 | Opposition(s) | 16.01.2023 | No opposition filed within time limit [2023/12] | Fees paid | Renewal fee | 27.08.2020 | Renewal fee patent year 03 | 27.08.2020 | Renewal fee patent year 04 | 27.08.2020 | Renewal fee patent year 05 | 17.05.2021 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2005113587 (GANYMED PHARMACEUTICALS AG [DE], et al); | [A]WO2008145338 (GANYMED PHARMACEUTICALS AG [DE], et al); | [A]WO2012038055 (UNICELL GMBH [DE], et al); | [A]WO2014146672 (GANYMED PHARMACEUTICALS AG [DE], et al); | by applicant | WO9633265 | WO9724447 | US2003118592 | US2003133939 |